These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 31581352)

  • 1. The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients.
    Gardiner BJ; Chow JK; Brilleman SL; Peleg AY; Snydman DR
    Transpl Infect Dis; 2019 Dec; 21(6):e13189. PubMed ID: 31581352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.
    Gardiner BJ; Chow JK; Price LL; Nierenberg NE; Kent DM; Snydman DR
    Clin Infect Dis; 2017 Nov; 65(12):2000-2007. PubMed ID: 29020220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
    Mabilangan C; Preiksaitis JK; Cervera C;
    Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
    Singh N; Winston DJ; Razonable RR; Lyon GM; Silveira FP; Wagener MM; Stevens-Ayers T; Edmison B; Boeckh M; Limaye AP
    JAMA; 2020 Apr; 323(14):1378-1387. PubMed ID: 32286644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.
    Mabilangan C; Preiksaitis J; Cervera C;
    Transpl Infect Dis; 2018 Oct; 20(5):e12964. PubMed ID: 29981174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.
    Gardiner BJ; Nierenberg NE; Chow JK; Ruthazer R; Kent DM; Snydman DR
    Clin Infect Dis; 2018 Oct; 67(9):1395-1402. PubMed ID: 29635432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation.
    Serrano-Alonso M; Guillen-Grima F; Martin-Moreno P; Rabago G; Manrique J; Garcia-Del-Barrio M; Reina G; Torre-Cisneros J; Fernandez-Alonso M; Herrero JI
    Transpl Infect Dis; 2018 Jun; 20(3):e12873. PubMed ID: 29512280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?
    Fernández-García OA; Hernandez C; Robbins M; Kabbani D; Doucette K; Cervera C
    Transpl Infect Dis; 2024 Aug; 26(4):e14292. PubMed ID: 38728099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
    Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
    BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease.
    Belga S; Hernandez C; Kabbani D; Cervera C
    Transpl Infect Dis; 2024 Apr; 26(2):e14227. PubMed ID: 38180285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation.
    Ekenberg C; da Cunha-Bang C; Lodding IP; Sørensen SS; Sengeløv H; Perch M; Rasmussen A; Gustafsson F; Wareham NE; Kirkby N; Kjaer J; Helleberg M; Reekie J; Lundgren JD
    Transpl Infect Dis; 2020 Apr; 22(2):e13252. PubMed ID: 31997565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
    Jaamei N; Koutsokera A; Pasquier J; Mombelli M; Meylan P; Pascual M; Aubert JD; Manuel O
    Transpl Infect Dis; 2018 Aug; 20(4):e12893. PubMed ID: 29603543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of a Weight-based Dosing Regimen of Valganciclovir for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients.
    Pappo A; Peled O; Berkovitch M; Bilavsky E; Rom E; Amir J; Krause I; Yarden-Bilavsky H; Scheuerman O; Ashkenazi-Hoffnung L
    Transplantation; 2019 Aug; 103(8):1730-1735. PubMed ID: 31343571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
    Navarro D; San-Juan R; Manuel O; Giménez E; Fernández-Ruiz M; Hirsch HH; Grossi PA; Aguado JM;
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28859257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of standardized protocols for cytomegalovirus disease prevention in pediatric solid organ transplant recipients.
    Ganapathi L; Blumenthal J; Alawdah L; Lewis L; Gilarde J; Jones S; Milliren C; Kim HB; Sharma TS
    Pediatr Transplant; 2019 Nov; 23(7):e13568. PubMed ID: 31515909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection in heart transplantation: A single center experience.
    Echenique IA; Angarone MP; Rich JD; Anderson AS; Stosor V
    Transpl Infect Dis; 2018 Aug; 20(4):e12896. PubMed ID: 29602266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
    Avery RK; Silveira FP; Benedict K; Cleveland AA; Kauffman CA; Schuster MG; Dubberke ER; Husain S; Paterson DL; Chiller T; Pappas P
    Transpl Infect Dis; 2018 Jun; 20(3):e12877. PubMed ID: 29512935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapsing cytomegalovirus infection in solid organ transplant recipients.
    Shanahan A; Malani PN; Kaul DR
    Transpl Infect Dis; 2009 Dec; 11(6):513-8. PubMed ID: 19735385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.
    Len O; Gavaldà J; Aguado JM; Borrell N; Cervera C; Cisneros JM; Cuervas-Mons V; Gurguí M; Martin-Dávila P; Montejo M; Muñoz P; Bou G; Carratalà J; Torre-Cisneros J; Pahissa A;
    Clin Infect Dis; 2008 Jan; 46(1):20-7. PubMed ID: 18171208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.